GlassScriptPhysician profile
Akhil Rasim Reddy
NPI 1447644075
$29,010.82
in general payments reported to CMS, 2019-2025
25 companies · $1,291 in 2025
The $1,291 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.96 · 2020: $217 · 2021: $3,628 · 2022: $2,974 · 2023: $17K · 2024: $3,612 · 2025: $1,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Travel and Lodging: $5,074 · Food and Beverage: $4,087 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $13,000.00 |
| Travel and Lodging | $5,073.66 |
| Food and Beverage | $4,087.24 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19,656.70 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Edwards Lifesciences Corporation | $5,469.29 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,086.91 | 2019-2024 | Mitraclip |
| Boston Scientific Corporation | $684.60 | 2020-2025 | General - Stents, Avvigo Guidance System |
| Penumbra, INC. | $386.86 | 2024-2025 | Indigo System |
| Inari Medical, INC. | $359.80 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $279.00 | 2020-2025 | Wainua |
| Shockwave Medical, INC | $206.02 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $170.28 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $156.95 | 2023-2024 | Lifevest |
| Novo Nordisk INC | $140.01 | 2024-2025 | Wegovy |
| Medtronic Vascular, INC. | $77.29 | 2020 | |
| Cvrx, INC. | $42.86 | 2025 | Barostim Neo System |
| Amgen INC. | $42.79 | 2020-2021 | |
| Scpharmaceuticals INC. | $36.10 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $35.16 | 2025 | Amvuttra |
| W. L. Gore & Associates, INC. | $28.86 | 2024-2025 | Gore Cardioform Septal Occluder |
| E.R. Squibb & Sons, L.L.C. | $22.85 | 2025 | Camzyos |
| Heartflow, INC. | $21.96 | 2025 | |
| Cleerly, INC. | $21.48 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Bridgebio Pharma, INC. | $20.14 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $18.82 | 2025 | |
| Merck Sharp & Dohme LLC | $16.25 | 2025 | Verquvo |
| Esperion Therapeutics, INC. | $15.41 | 2025 | Nexletol |
| Lilly USA, LLC | $14.43 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akhil Rasim Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.